Literature DB >> 2443532

Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus.

M H Lee1, K Sano, F E Morales, D T Imagawa.   

Abstract

A sensitive biochemical assay of viral reverse transcriptase (RT) was developed that is useful for both the detection and quantitation of human immunodeficiency virus (HIV), the agent responsible for acquired immune deficiency syndrome in humans. This assay gave a 20- to 40-fold increase in enzyme activity over the current method used for RT detection of HIV. The test is based on a previous biochemical study showing the unusual stability of avian oncornavirus RNA-dependent DNA polymerases at 30 degrees C for at least 2 days. Our study shows that the HIV polymerase is stable at 30 to 37 degrees C for up to 3 days. By using this sensitive RT assay, as few as 250 HIV virions can be quantitated directly in tissue culture medium. This assay should prove useful in studies in which the detection of HIV or the quantitation of the number of virions is required.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443532      PMCID: PMC269314          DOI: 10.1128/jcm.25.9.1717-1721.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line.

Authors:  H M Rho; B Poiesz; F W Ruscetti; R C Gallo
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

3.  A very sensitive biochemical assay for detecting and quantitating avian oncornaviruses.

Authors:  A Tereba; K G Murti
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

4.  Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.

Authors:  F Brun-Vezinet; C Rouzioux; F Barre-Sinoussi; D Klatzmann; A G Saimot; W Rozenbaum; D Christol; J C Gluckmann; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1984-06-09       Impact factor: 79.321

5.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

6.  Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS.

Authors:  M Essex; M F McLane; T H Lee; L Falk; C W Howe; J I Mullins; C Cabradilla; D P Francis
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

7.  In vitro system for production of mouse mammary tumor virus.

Authors:  D L Fine; L O Arthur; J K PLOWMAN; E A Hillman; F Klein
Journal:  Appl Microbiol       Date:  1974-12

8.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Authors:  J Schüpbach; M Popovic; R V Gilden; M A Gonda; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  27 in total

1.  Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export.

Authors:  X J Yao; H Göttlinger; W A Haseltine; E A Cohen
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin.

Authors:  X J Yao; M A Wainberg; M Richard; M Pollak
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

3.  A simple and rapid reverse transcriptase assay for the detection of retroviruses in cell cultures.

Authors:  H Kuno; H Ikeda; M Takeuchi; T Yoshida
Journal:  Cytotechnology       Date:  1999-05       Impact factor: 2.058

4.  The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells.

Authors:  R Lodge; J P Lalonde; G Lemay; E A Cohen
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

5.  The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.

Authors:  Z Nie; D Bergeron; R A Subbramanian; X J Yao; F Checroune; N Rougeau; E A Cohen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 6.  Transgenic cell lines for detection of animal viruses.

Authors:  P D Olivo
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

7.  Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility.

Authors:  André F A Santos; Denis M Tebit; Matthew S Lalonde; Ana B Abecasis; Annette Ratcliff; Ricardo J Camacho; Ricardo S Diaz; Ottmar Herchenröder; Marcelo A Soares; Eric J Arts
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

8.  SIV infection duration largely determines broadening of neutralizing antibody response in macaques.

Authors:  Fan Wu; Ilnour Ourmanov; Andrea Kirmaier; Sivan Leviyang; Celia LaBranche; Jinghe Huang; Sonya Whitted; Kenta Matsuda; David Montefiori; Vanessa M Hirsch
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

9.  Haematological and lymphocyte subset analyses in sheep inoculated with bovine immunodeficiency-like virus.

Authors:  R M Jacobs; H E Smith; C A Whetstone; D L Suarez; B Jefferson; V E Valli
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

10.  Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog.

Authors:  H Soudeyns; X I Yao; Q Gao; B Belleau; J L Kraus; N Nguyen-Ba; B Spira; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.